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Background: Circulating asymmetric dimethylarginine (ADMA) has been associated with cardiovascular (CV) risk and disease in at-risk 
populations, but less is known regarding symmetric dimethylarginine (SDMA), and neither has been adequately studied in the general population.
Methods: ADMA and SDMA were measured in 2995 subjects in the Dallas Heart Study. Prevalent coronary calcium (CAC) measured by electron 
beam CT (n=2678) was defined by Agatston score >10. All-cause and CV death were recorded from the National Death Index, analyzed using 
multivariable logistic regression with ADMA and SDMA log transformed due to skewness of the distribution.
Results: The study cohort included 52% Black; 17% Hispanic; 56% women; 12% diabetes; 34% hypertension; median age 43 yrs. Median mortality 
follow-up was 6.4 yrs. Overall, CAC prevalence was 21%. In multivariable analyses adjusted for traditional CV risk factors, log SDMA was associated 
with CAC (adjusted OR 1.15 per SD increase, 95% CI 1.03-1.29); but log ADMA was not (adjusted OR=1.04, 95% CI 0.92-1.17). In multivariable 
models testing both covariates, SDMA but not ADMA was an independent predictor of all-cause mortality (adjusted HR 1.44 per SD increase, 95% CI 
1.26 -1.44; p<0.001) and CV death (HR 1.46 per SD increase, 95% CI 1.19 -1.78). Crude graded associations across quartiles of SDMA are shown 
in the Figure.
Conclusions: In the general population, serum SDMA but not ADMA independently predicts coronary atherosclerosis as well as all-cause and CV 
mortality.
